H9

Information for H9

Description

Human acute lymphoblastic leukemia cell line.

Source BRENDA Tissue Ontology (BTO)

ReMap Statistics

Datasets
14
Transcriptional Factors
13
Peaks
411,514
Non-redundant peaks
350,669

Description

Cell_name
H9
Category
Cancer cell line
Disease
NCIt; C9265; Mycosis fungoides and Sezary syndrome
Sex_gender_of_cell
Male
Age_of_donor
53Y

External IDs

Cellosaurus
CVCL_1240
Experimental Factor
EFO_0003045
BRENDA Tissue
BTO:0001944
Wiki
H9
ATCC
H9
Synonyms
H 9; H-9; HT clone H9; HT(H9)
All peaks H9
Download BED file
Non redundant H9
Download BED file
DOWNLOAD All ReMap
Go to catalogue

Datasets Table for H9

Biotype Biotype modification Ecotype Target name Target modification Source Species Experiment Peaks
H9 FOXA2 ENA Homo sapiens ERP004206 Download (138,995)
H9 GATA6 ENA Homo sapiens ERP004206 Download (2,027)
H9 HNF1B ENA Homo sapiens ERP004206 Download (2,760)
H9 ONECUT1 ENA Homo sapiens ERP004206 Download (50,558)
H9 PDX1 ENA Homo sapiens ERP004206 Download (2,634)
H9 FOXP1 GEO Homo sapiens GSE31006 Download (42,551)
H9 TP53 GEO Homo sapiens GSE39912 Download (2,839)
H9 SOX2 GEO Homo sapiens GSE46837 Download (3,216)
H9 MORC2 GEO Homo sapiens GSE95374 Download (16,584)
H9 MPHOSPH8 GEO Homo sapiens GSE95374 Download (17,063)
H9 DOX PAX7 GEO Homo sapiens GSE98976 Download (21,809)
H9 derived-cIN NKX2-1 GEO Homo sapiens GSE99937 Download (53,419)
H9 ENDODERM T GEO Homo sapiens GSE60606 Download (23,419)
H9 MESODERM T GEO Homo sapiens GSE60606 Download (33,640)
Biotype Biotype modification Ecotype Target name Target modification Source Species Experiment Peaks

ReMap is a database of transcriptional regulators peaks derived from curated ChIP-seq, ChIP-exo, DAP-seq experiments in Human and Thaliana.

You are using the 2020 ReMap (3rd) release.
The ReMap catalogues (2020, 2018, 2015) are under CC BY-NC 4.0 international license, while ReMapEnrich, remap-pipeline under GNU GPLv3 licence.

Inserm TAGC
AMU AMU-MESO

This work was granted access to the HPC resources of Aix-Marseille Université financed by the project Equip@Meso (ANR-10-EQPX-29-01) of the program "Investissements d’Avenir" supervised by the Agence Nationale de la Recherche.